Search clinical trials for: Methylphenidate Transdermal System

Total 77901 results

Cryopraxis Criobiologia Ltda.
Hospital Federal de Bonsucesso

Unknown

Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid (LipAge)

Lipodystrophies | Aesthetics Procedure

Brazil
Arkansas Tech University

Completed

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

No Condition Salivary Alpha Amylase

United States
Mayo Clinic
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Testing Methylphenidate for Smoking Abstinence

Smoking

United States
University of Bristol
Royal United Hospitals Bath NHS Foundation Trust

Recruiting

CHIEF PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease) (CHIEF PD)

Parkinson Disease

United Kingdom
ZARS Pharma Inc.

Completed

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

Pain | Osteoarthritis, Knee

United States
Zynerba Pharmaceuticals, Inc.

Enrolling by invitation

Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

Fragile X Syndrome

United States, United Kingdom, New Zealand, Australia
University of Virginia

Not yet recruiting

Feasibility of Delivering VergeRx at FQHCs

Tobacco Use Cessation

United States
Bayer

Completed

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan (JULINA-CLIMA)

Osteoporosis, Postmenopausal

Japan
Sir Charles Gairdner Hospital

Unknown

Topical Magnesium and Muscle Cramps in Dialysis Patients.

Chronic Kidney Diseases | End Stage Renal Disease | Dialysis Related Complications
Bayer

Completed

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Osteoporosis, Postmenopausal

Japan
Janssen Pharmaceutical K.K.

Completed

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Pain | Cancer

Japan
Medical University of South Carolina
Shire

Completed

Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD

Adult Attention Deficit Hyperactivity Disorder (ADHD)

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers

Healthy

Belgium
Monash Medical Centre
Monash University

Recruiting

FASST - Fetal Alcohol Spectrum Stimulant Trial (FASST)

Fetal Alcohol Spectrum Disorders

Australia
Data Collection Analysis Business Management

Unknown

Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications

Pain, Chronic | Pain Syndrome | Pain, Joint

United States
Neogenix, LLC dba Ogenix
University of Maryland, College Park

Recruiting

Oxygen for Vascular Incisional Healing

Incision | Revascularization | Surgical Wound Healing | Lower Extremity

United States
Arkansas Tech University

Active, not recruiting

Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation

Electroencephalography | no Condition | Pupil Diameter

United States
VasoLead (2012) Ltd.

Unknown

Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction

Erectile Dysfunction

Israel
Mylan Pharmaceuticals Inc

Completed

Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

Healthy

United States
Massachusetts General Hospital
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults

Healthy

United States
Novartis Pharmaceuticals

Completed

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Attention Deficit/Hyperactivity Disorder

Germany, United States, Belgium, Colombia, Denmark, Sweden
Janssen-Cilag International NV

Completed

Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

France, Germany, Spain, Switzerland, Netherlands, Portugal, Norway
Alza Corporation, DE, USA

Withdrawn

An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients

Pain, Postoperative | Pediatrics
Saint Vincent's Hospital, Korea

Recruiting

Transdermal Trigeminal Electrical Neuromodulation on Mild Cognitive Impairment With Insomnia

Insomnia | Alzheimer Disease | Mild Cognitive Impairment | Amyloid

Korea, Republic of
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy

United States
Ajou University School of Medicine

Unknown

New Application of Buprenorphine Patch on Painful Knee Joint in Knee Osteoarthritis Patients

Knee Osteoarthritis
Mensia Technologies SA
European Union H2020 SME Instrument

Unknown

Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder (Newrofeed)

Attention Deficit-Hyperactivity Disorder

France, Belgium, Germany, Spain, Switzerland
Neogenix, LLC dba Ogenix

Withdrawn

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion

Instrumented Spinal Fusion

United States
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
MediBeacon

Completed

A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants

Kidney Diseases | Kidney Injury | Kidney Failure

China
Janssen-Cilag International NV

Completed

A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit/ Hyperactivity Disorder

France, Belgium, Germany, Spain, Switzerland, Denmark, Finland, Netherlands, Norway, Sweden, United Kingdom
Cure Therapeutics

Unknown

Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow

Tendonitis

Poland
VA Nebraska Western Iowa Health Care System

Completed

Role of Apathy in the Effectiveness of Weight Loss Interventions

Obesity | Apathy

United States
Zynerba Pharmaceuticals, Inc.

Completed

Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX) (CONNECT-FX)

Fragile X Syndrome

United States, New Zealand, Australia
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay

Healthy

United States
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
Prof. Huss

Terminated

Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA) (ASTA)

ADHD

Germany
Lumara Health, Inc.

Completed

Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms

Hot Flashes

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

Normal Physiology

United States
Shaare Zedek Medical Center

Completed

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

ADHD

Israel
Hospices Civils de Lyon

Completed

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

Neurofibromatosis Type 1

France
National Center for Research Resources (NCRR)
Murray Fellowship

Completed

Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery

Brain Injuries

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System

Healthy

Canada
University of North Texas, Denton, TX
The University of Texas Health Science Center at San Antonio

Recruiting

Deposit Contracts to Increase Accessibility of a Contingency Management Intervention to Reduce Problematic Drinking

Contingency Management | Alcohol Abuse | Alcohol Intervention | Transdermal Alcohol Monitoring | Deposit Contract

United States
Noven Pharmaceuticals, Inc.

Completed

Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. (HP-3070)

Schizophrenia

United States
Rhodes Pharmaceuticals, L.P.

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD (PK003)

Attention-Deficit/Hyperactivity Disorder

United States
Yale University
Autism Speaks

Completed

Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism

Aggression | Autism Spectrum Disorder | Irritability

United States
Vanderbilt University Medical Center

Completed

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Breast Cancer | Chemotherapy-related Cognitive Impairment | Chemo Fog | Chemo Brain | Chemobrain

United States
Shenox Pharmaceuticals, LLC

Unknown

Ketamine for Major Depressive Disorder

Major Depressive Disorder

United States
Janssen-Ortho Inc., Canada

Completed

CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.

Depressive Disorder, Major
Utrecht Institute for Pharmaceutical Sciences

Completed

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

ADHD

Netherlands

Search clinical trials for: Methylphenidate Transdermal System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations